UCB Obtains European Antitrust Clearance for Take-Over of SCHWARZ PHARMA

23-Nov-2006

UCB announced that the EU Commission has cleared the proposed take-over of SCHWARZ PHARMA by UCB. As announced on November 10, 2006, the U.S. Federal Trade Commission (FTC) has allowed the waiting period to expire without expressing any concerns. Therefore, the take-over of SCHWARZ PHARMA by UCB can be pursued both from a European and U.S. antitrust perspective.

UCB announced the commencement of the acceptance period for the take-over of SCHWARZ PHARMA which is from November 10, 2006 until December 8, 2006, 24:00 hours (CET). On November 20, 2006, the Executive Board and Supervisory Board of the SCHWARZ PHARMA AG recommended acceptance of the offer by UCB to the shareholders of SCHWARZ PHARMA AG.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance